Tarrytown, NY, United States of America

Michael E Dunn

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tarrytown, NY (US) (2022)
  • Montvale, NJ (US) (2022 - 2023)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael E Dunn: Innovator in Medical Technology

Introduction

Michael E Dunn is a prominent inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medical technology, holding a total of 5 patents. His work focuses on innovative solutions that enhance medical practices and improve patient outcomes.

Latest Patents

One of his latest patents involves immunoglobulin proteins that bind to NPR1 agonists. This patent provides novel immunoglobulin proteins that interact with a human natriuretic peptide receptor 1 (NPR1) agonist, specifically an anti-NPR1 antibody. The proteins described in this patent are designed to block or reverse the effects of administered anti-NPR1 antibodies, which can be crucial for managing blood pressure and hemodynamics in humans.

Another significant patent pertains to a medical imaging table, which includes a table assembly for supporting a subject in various examination positions. This system features a table support assembly with moving mechanisms that allow for precise movement and rotation of the table assembly. Additionally, it includes a probe support assembly that holds a probe and is designed to maintain a predetermined position and orientation relative to the table assembly, facilitating accurate imaging procedures.

Career Highlights

Michael E Dunn is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to innovate in the medical field. His work has been instrumental in developing technologies that enhance diagnostic and therapeutic capabilities.

Collaborations

Throughout his career, Michael has collaborated with notable colleagues, including Lori C Morton and Jia Su. These partnerships have contributed to the advancement of his projects and the successful development of his patents.

Conclusion

Michael E Dunn exemplifies the spirit of innovation in medical technology through his patents and contributions to Regeneron Pharmaceuticals, Inc. His work continues to impact the field positively, paving the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…